Literature DB >> 11353571

Are sleep-related breathing disorders important contributing factors to the production of essential hypertension?

D S Silverberg1, A Oksenberg.   

Abstract

About 50% of all patients with essential hypertension have obstructive sleep apnea (OSA), and another 40% of essential hypertension patients are habitual snorers, but without OSA. There is now convincing evidence that both OSA and habitual snoring are independent risk factors for essential hypertension, and that treatment of OSA will reduce the blood pressure. There is also some evidence that treatment of habitual snoring will also reduce the blood pressure. If this is the case, then we postulate a unifying hypothesis: that these two sleep-related breathing disorders (SRBD) (OSA and habitual snoring) are very common contributing factors to what is called "essential hypertension." The many epidemiologic, clinical, hematologic, biochemical, and physiologic findings seen in essential hypertension could also be due to the associated SRBD. A routine search for SRBD by asking a few simple questions of all patients (especially those with hypertension) and their bed partners could increase the number of patients detected and treated significantly. Successful treatment of SRBD would improve sleep quality and the associated excessive daytime sleepiness, and thus improve the quality of life. In addition, there is a good chance that the hypertension will improve as well.

Entities:  

Mesh:

Year:  2001        PMID: 11353571     DOI: 10.1007/s11906-001-0040-8

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  54 in total

1.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

2.  Sleep-disordered breathing and hypertension.

Authors:  F M Brouwers; J W Lenders
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

3.  Snoring, pregnancy-induced hypertension, and growth retardation of the fetus.

Authors:  K A Franklin; P A Holmgren; F Jönsson; N Poromaa; H Stenlund; E Svanborg
Journal:  Chest       Date:  2000-01       Impact factor: 9.410

4.  Positional vs nonpositional obstructive sleep apnea patients: anthropomorphic, nocturnal polysomnographic, and multiple sleep latency test data.

Authors:  A Oksenberg; D S Silverberg; E Arons; H Radwan
Journal:  Chest       Date:  1997-09       Impact factor: 9.410

5.  Snoring as part of a dose-response relationship between sleep-disordered breathing and blood pressure.

Authors:  T Young; L Finn; K M Hla; B Morgan; M Palta
Journal:  Sleep       Date:  1996-12       Impact factor: 5.849

Review 6.  Essential and secondary hypertension and sleep-disordered breathing: a unifying hypothesis.

Authors:  D S Silverberg; A Oksenberg
Journal:  J Hum Hypertens       Date:  1996-06       Impact factor: 3.012

7.  Snoring and risk of cardiovascular disease in women.

Authors:  F B Hu; W C Willett; J E Manson; G A Colditz; E B Rimm; F E Speizer; C H Hennekens; M J Stampfer
Journal:  J Am Coll Cardiol       Date:  2000-02       Impact factor: 24.094

8.  Association of hypertension and sleep-disordered breathing.

Authors:  E O Bixler; A N Vgontzas; H M Lin; T Ten Have; B E Leiby; A Vela-Bueno; A Kales
Journal:  Arch Intern Med       Date:  2000 Aug 14-28

9.  Effect of short term graded withdrawal of nasal continuous positive airway pressure on systemic blood pressure in patients with obstructive sleep apnoea.

Authors:  J R Stradling; J Partlett; R J Davies; D Siegwart; L Tarassenko
Journal:  Blood Press       Date:  1996-07       Impact factor: 2.835

10.  The occurrence of sleep-disordered breathing among middle-aged adults.

Authors:  T Young; M Palta; J Dempsey; J Skatrud; S Weber; S Badr
Journal:  N Engl J Med       Date:  1993-04-29       Impact factor: 91.245

View more
  23 in total

Review 1.  The Use of Precision Medicine to Manage Obstructive Sleep Apnea Treatment in Patients with Resistant Hypertension: Current Evidence and Future Directions.

Authors:  Esther Sapiña; Gerard Torres; Ferran Barbé; Manuel Sánchez-de-la-Torre
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

2.  White coat hypertension and obstructive sleep apnea.

Authors:  Li Li; Li-Zhu Guo; Jie Li; Ying Wang; Xin Liu; Ya-Hui Lv; Chang-Sheng Ma
Journal:  Sleep Breath       Date:  2015-02-14       Impact factor: 2.816

Review 3.  The pathophysiology of hypertension in patients with obesity.

Authors:  Vincent G DeMarco; Annayya R Aroor; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2014-04-15       Impact factor: 43.330

Review 4.  The Potential Role of Obstructive Sleep Apnoea in Refractory Hypertension.

Authors:  Grace Oscullo; E Sapiña-Beltrán; Gerard Torres; Enrique Zaldivar; Ferran Barbé; Miguel Angel Martinez-Garcia
Journal:  Curr Hypertens Rep       Date:  2019-06-10       Impact factor: 5.369

Review 5.  Resistant hypertension.

Authors:  David A Calhoun; Mohammad A Zaman; Mari K Nishizaka
Journal:  Curr Hypertens Rep       Date:  2002-06       Impact factor: 5.369

6.  Nighttime hypoxia affects global cognition, memory, and executive function in community-dwelling individuals with hypertension.

Authors:  Iolanda Riba-Llena; José Álvarez-Sabin; Odile Romero; Estevo Santamarina; Gabriel Sampol; Olga Maisterra; Álex Ferré; Joan Montaner; Manuel Quintana; Pilar Delgado
Journal:  J Clin Sleep Med       Date:  2020-01-13       Impact factor: 4.062

Review 7.  Sleep: important considerations for the prevention of cardiovascular disease.

Authors:  Michael A Grandner; Pamela Alfonso-Miller; Julio Fernandez-Mendoza; Safal Shetty; Sundeep Shenoy; Daniel Combs
Journal:  Curr Opin Cardiol       Date:  2016-09       Impact factor: 2.161

Review 8.  Insulin resistance and the sympathetic nervous system.

Authors:  Brent M Egan
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

Review 9.  OSA: the new cardiovascular disease: part II: Overview of cardiovascular diseases associated with obstructive sleep apnea.

Authors:  Kiran Devulapally; Raymond Pongonis; Rami Khayat
Journal:  Heart Fail Rev       Date:  2008-08-29       Impact factor: 4.214

10.  The interaction between hypertension and obstructive sleep apnea on subjective daytime sleepiness.

Authors:  Wilson Tam; Susanna S Ng; Kin-Wang To; Fanny W Ko; David S Hui
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-02-06       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.